---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-070367"
form_type: "8-K"
ticker: null
cik: "0001792581"
company_name: "Kiromic Biopharma, Inc."
filed_at: "2023-06-12T23:59:59+00:00"
generated_at: "2026-06-14T03:07:15.609082+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Kiromic BioPharma appoints Brian Hungerford as interim CFO

## Summary
- Appointed Brian Hungerford as interim Chief Financial Officer effective June 12, 2023.
- Mr. Hungerford was retained through an agreement with Element 78 Partners, LLC.
- No departure of prior CFO or other officers was disclosed.

## SEC filing metadata
- accession: 0001104659-23-070367
- form_type: 8-K
- cik: 0001792581
- company_name: Kiromic Biopharma, Inc.
- filed_at: 2023-06-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1792581/000110465923070367/0001104659-23-070367-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1792581/000110465923070367/tm2318467d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-070367
- JSON: https://secwatch.observer/filing/0001104659-23-070367.json
- Plain text: https://secwatch.observer/filing/0001104659-23-070367.txt

## Key facts
- Executive change
  Brian Hungerford was appointed as interim Chief Financial Officer at Kiromic Biopharma, Inc..
  - Action: appointed
  - Role: interim Chief Financial Officer
  source text: On June 12, 2023, Kiromic BioPharma, Inc. (the "Company") appointed Brian Hungerford as interim Chief Financial Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1792581/000110465923070367/0001104659-23-070367-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.